Acid Togni-(4-MeO-PhOCF2CF2)-reagent, 95.0%, 250mg

7-Bromo-3,4-dihydro-2H-1,5-benzodioxepine, 98%, 250mg

MITOXANTRONE, 95%, 250mg

1H-Indol-5-ylmethanol, 95.0%, 1g

Fmoc-Lys-OH, 95%, 25g

N-(9,9-DIMETHYL-9H-FLUOREN-2-YL)-9,9-DIPHENYL-9H-FLUOREN-2-AMINE, 95%, 1g

1,4-Dimethyl-1H-1,2,3-triazole, 95.0%, 1g

GC capillary column ROTI®Cap-1701, 30 m, 0.32 mm, 1.00 µm, 1 Piece(s)

(R)-tert-Butyl 2-(aminomethyl)morpholine-4-carboxylate acetate, 97.0%, 250mg

Prothionamide>98.0%(HPLC)(T)5g

(R)-3-Hydroxybutanoic acid, 95.0%, 25g

2-Chloro-4,5-difluorobenzaldehyde, 95.0%, 25g

8-Bromo-2-chloro-6-fluoroquinoline, 97%, 100mg